Sorry, you need to enable JavaScript to visit this website.

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries (also called layperson summaries, plain language summaries, lay language summaries, simple summaries, and trial results summaries) are intended to make the clinical results of these studies understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.  For more information about a specific study, please visit ClinicalTrials.gov on the ClinicalTrials.gov Identifier (NCT) link on the study results page.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Avelumab in Previously Untreated Patients with Epithelial Ovarian Cancer (Javelin Ovarian 100)
Category & Conditions: Cancer
Study Phase : 3
Medicine: BAVENCIO(AVELUMAB)
PrintDownload
Study to Provide Access to Palbociclib and Letrozole For Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer That has Spread to Other Parts of the Body
Category & Conditions: Cancer
Study Phase : 3
Medicine: IBRANCE®(PALBOCICLIB)
PrintDownload
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clon
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: LYRICA® AND LYRICA®CR(PREGABALIN) AND (PREGABALIN EXTENDED RELEASE TABLETS)
PrintDownload
Testing the safety and effectiveness of Pregabalin in pediatric and adult patients with primary generalized (PGTC) seizures, which is a disturbance in the functioning of both sides of the brain
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: LYRICA® AND LYRICA®CR(PREGABALIN) AND (PREGABALIN EXTENDED RELEASE TABLETS)
PrintDownload
A Randomized Trial of Sildenafil in Babies with Breathing Problems
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: REVATIO®(SILDENAFIL)
PrintDownload
A Trial to Measure the Safety and Efficacy of Vyndaqel Treatment in Patients With Transthyretin Amyloid Cardiomyopathy
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
PrintDownload
Efficacy and safety of tofacitinib in young patients aged 2 to less than 18 years with polyarticular course Juvenile Idiopathic Arthritis (JIA)
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: XELJANZ®(TOFACITINIB)
PrintDownload
Study to Measure the Efficacy and Safety of Abrocitinib (PF-04965842) in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis (JADE Mono-1)
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownload
Study to Measure the Efficacy and Safety of Abrocitinib (PF-04965842) in Subjects Aged 12 Years And Older, With Moderate to Severe Atopic Dermatitis
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownload
Study to compare avelumab in combination with standard of care chemoradiotherapy (SoC CRT) versus SoC CRT for definitive treatment in patients with locally advanced squamous cell carcinoma of the head and neck (JAVELIN HEAD AND NECK 100)
Category & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab)
PrintDownload
Avelumab In Combination Treatments in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (Javelin DLBCL)
Category & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab), PF-05082566
PrintDownload
Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
PrintDownload
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
PrintDownload
Safety and Pain Relief of Tanezumab in Patients with Osteoarthritis of the Hip or Knee
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: tanezumab
PrintDownload
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer (PREVAIL)
Category & Conditions: Cancer
Study Phase : 3
Medicine: Xtandi (enzalutamide)
PrintDownload
Study Investigating if Treatment with Rivipansel Shortened the Length of Hospital Stay For Patients with Sickle Cell Disease Vaso-Occlusive Crisis
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: Rivipansel (GMI-1070)
PrintDownload
Immunogenicity and Safety Study of 1 and 2 Doses of Meningococcal Vaccine MenACWY-TT in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13® Vaccine
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine), PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
PrintDownload